Release Date: 29/08/19 08:12 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 1.87MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%